300 hours. This is the common answer to the question, “How long should I study for the CPA exam?” But is this truly enough study time to pass the CPA exam? If not, how many hours are enough? And is ...

Five-day Eid break for students, teachers and admin staff File photo of visitors enjoying a fireworks display at the Dubai Frame on the occasion of Eid Al Adha. Gulf News The Ministry of Education has ...

April 27 (Reuters) - Oruka Therapeutics (ORKA.O), opens new tab said on Monday that interim results showed its experimental drug helped clear psoriasis within 16 weeks, meeting the main goal ‌of a mid ...

April 7 (Reuters) - Insmed (INSM.O), opens new tab said on Tuesday it ‌would discontinue the development of its treatment for a chronic, inflammatory skin condition, after the drug failed a mid-stage ...

In the aftermath of the latest bout of extreme rainfall across New Zealand's upper North Island, there were some familiar scenes. As we count the toll of these events, which have wrought billions of ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Assessing intermediate coronary lesions with an intracoronary pressure wire improves clinical outcomes in patients undergoing cardiac catheterization and percutaneous coronary intervention (PCI).

A new study suggests that chemicals found in python blood may help regulate appetite, potentially inspiring future weight-loss drugs. Researchers say the findings could lead to innovative treatments ...

New Sacramento State football coach Alonzo Carter stands alongside university president Luke Wood, left, and athletic director Mark Orr during his introductory news conference on Dec. 18, 2025. HECTOR ...

Elia projected, "On a projected basis, we anticipate suitable for robust assessment of VYD2311 effectiveness if the clinical performance of VYD2311 matches our modeling and prior experience with COVID ...

Sanofi has backed the $75 million series B of a rhinovirus-focused biotech with a former FDA acting commissioner at the helm. Altesa BioSciences unveiled back in 2022 with $4 million in seed funding ...